Author:
O'Hara Jamie,Finnegan Alan,Dhillon Harpal,Ruiz-Casas Leonardo,Pedra Gabriel,Franks Bethany,Morgan George,Hebditch Vanessa,Jönsson Bengt,Mabhala Mzwandile,Reic Tatjana,Van Thiel Ingo,Ratziu Vlad,Romero-Gomez Manuel,Bugianesi Elisabetta,Schattenberg Jörn M.,Anstee Quentin M.
Funder
Novo Nordisk
Gilead Sciences, Europe Ltd
Subject
Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine
Reference31 articles.
1. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis;Anstee;Nat Rev Gastroenterol,2013
2. NASH: a global health problem;Sanyal;Hepatol Res,2011
3. Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment;Weiß;Dtsch Arztebl Int,2014
4. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030;Estes;J Hepatol,2018
5. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献